Director at Stock Yards Bancorp ($SYBT) Awarded Stock Rights
Stock Yards Bancorp, Inc.
Subscribe to track SYBT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Director at Stock Yards Bancorp ($SYBT) Awarded Stock Rights
Company: Stock Yards Bancorp, Inc. (SYBT) Form: 4 | Filed: 2025-10-22 Significance: Low
Insider: Hardy David L. Title: null | Relationship: Director
Transaction: • Type: Grant • Security: Stock Appreciation Right • Shares: 1,000 • Price: $0.00 • Value: $0 • Owned After: 1,000 (SARs)
Key Insight: A routine grant of 1,000 Stock Appreciation Rights to a director as part of their compensation package. The transaction has no immediate market value and represents minimal potential dilution.
Market Context: This grant represents less than 0.004% of total shares outstanding, indicating a non-material event for the $2.01 billion company.
Comprehensive Analysis
SEC Filing Analysis: Stock Yards Bancorp, Inc. (SYBT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director was awarded 1,000 Stock Appreciation Rights (SARs) as part of a standard compensation plan, a routine event with no immediate market impact.
- Market Impact: Neutral. This is a non-cash compensation grant and is too small to influence market sentiment or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | Stock Yards Bancorp, Inc. |
| Ticker Symbol | SYBT |
| CIK | 0000835324 |
| Industry | STATE COMMERCIAL BANKS [6022] |
Insider Information
| Field | Value |
|---|---|
| Name | Hardy David L. |
| CIK | 0002092903 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-21 |
| Transaction Code | A (Grant) |
| Security Type | Stock Appreciation Right |
| Shares Involved | 1,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 1,000 (of this security) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 1,000 |
| % of Shares Outstanding | 0.0034% |
| Post-Transaction Ownership | 1,000 SARs |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $2.01 billion, a grant with a $0 transaction value is immaterial.
- Ownership Concentration: This grant gives the director rights equivalent to a very small fraction of the company's equity. The post-transaction holding of 1,000 SARs is not a significant ownership stake.
- Dilution Impact: The potential dilution from this grant is minimal, representing only 0.0034% of the total shares outstanding. This level of dilution is negligible and is a routine part of equity-based compensation plans.
- Transaction Significance: The transaction is classified as low significance. It is a standard equity award, not an open-market transaction, and its size relative to both market cap and shares outstanding is extremely small.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to insiders are common and expected forms of compensation. They do not signal new information about the company's prospects and are not market-moving events, especially at this small scale.
Volume & Sentiment
- Expected Volume Impact: None. As this is not an open-market transaction, it will not directly affect trading volume.
- Sentiment Indicator: Neutral. The market generally views such routine compensation grants as a normal course of business.
Investment Insights
Positive Market Indicators
- Aligning insider interests with shareholders through equity compensation is a standard governance practice.
Risk Factors
- No immediate risk factors are presented by this filing.
Key Takeaways
- Routine Compensation: This is a standard grant of Stock Appreciation Rights to a director, not an insider buy or sell.
- No Market Signal: The transaction does not provide any new insight into the insider's view of the company's future performance.
- Immaterial Impact: The size of the grant is negligible relative to the company's market capitalization and total shares outstanding, resulting in no meaningful financial or market impact.
Additional Context
Transaction Notes
- Terms: The Stock Appreciation Rights have an exercise price of $67.85, become exercisable on October 21, 2026, and expire on October 21, 2035.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
